Manufacturing of therapeutic satellite cells for treating muscular dystrophy
AssigneeVita Therapeutics, Inc.
InventorsCongshan SUN, Amir SABERI, Peter Andersen, Douglas FALK, Yongming REN, Sheela JACOB, Jeff HARDING, Amy WESA
Life of this patent
Estimating the term…
Abstract
The present disclosure provides compositions and methods for preparing autologous satellite cells that have restored a dysfunctional gene involved in muscular dystrophy of a patient. Such implanted satellite cells can promote repair and recovery of myofibrils and muscles in the patients, thereby treating muscular dystrophy in the patient.
Claims22
A method for preparing a satellite cell from a stem cell comprising a mutation in an endogenous gene, comprising:
- introducing to the stem cell a first and a second vectors, each comprising a first expression cassette encoding at least part of the wild-type gene, such that each of the first expression cassettes is integrated at a locus of the endogenous gene in the genome to enable coding of a wild-type version of the gene without the mutation;
- differentiating the stem cell into a satellite cell;
- and
- expanding the satellite cell into a population of satellite cells.
A method for preparing a satellite cell from a stem cell comprising a mutation in an endogenous gene, comprising:
- introducing to the stem cell a first and a second vectors, each comprising a first expression cassette comprising all coding sequences of the wild-type gene, such that each of the first expression cassettes is integrated at a locus in the genome different from the endogenous gene;
- differentiating the stem cell into a satellite cell;
- and
- expanding the satellite cell into a population of satellite cells.
19-22. (canceled)
(canceled)
Dependencies are inferred from the claim text.